Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLSE Pulse Biosciences

Closed 09-04 16:00:00 EDT

53.24

-1.47

-2.69%

盘后53.27

+0.03+0.06%

19:38 EDT

High54.75	Low52.75	Vol515.42K
Open53.68	D1 Closing54.71	Amplitude3.66%
Mkt Cap3.80B	Tradable Cap1.11B	Total Shares71.32M
T/O27.61M	T/O Rate2.48%	Tradable Shares20.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLSE","market":"US","secType":"STK","nameCN":"Pulse Biosciences","latestPrice":53.24,"timestamp":1788552000000,"preClose":54.71,"halted":0,"volume":515418,"hourTrading":{"tag":"盘后","latestPrice":53.27,"preClose":53.24,"latestTime":"19:38 EDT","volume":7492,"amount":398984.1244,"timestamp":1788565116751,"change":0.03,"changeRate":0.000563,"amplitude":0.005823},"delay":0,"changeRate":-0.026868945348199575,"floatShares":20814288,"shares":71322600,"eps":-1.175648,"marketStatus":"Closed","change":-1.47,"latestTime":"09-04 16:00:00 EDT","open":53.68,"high":54.75,"low":52.75,"amount":27614462.56494,"amplitude":0.036556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.175648,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1463544000000,"exchange":"NASDAQ","adjPreClose":54.71,"preHourTrading":{"tag":"盘前","latestPrice":54,"preClose":54.71,"latestTime":"09:13 EDT","volume":649,"amount":35094.385546,"timestamp":1788527584876,"change":-0.71,"changeRate":-0.012978,"amplitude":0.009505},"postHourTrading":{"tag":"盘后","latestPrice":53.27,"preClose":53.24,"latestTime":"19:38 EDT","volume":7492,"amount":398984.1244,"timestamp":1788565116751,"change":0.03,"changeRate":0.000563,"amplitude":0.005823},"volumeRatio":0.688276,"impliedVol":0.6623,"impliedVolPercentile":0.6944},"requestUrl":"/m/hq/s/PLSE","defaultTab":"news","newsList":[{"id":"2664339364","title":"Pulse Biosciences announces inducement grants under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339364","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339364?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:10","pubTimestamp":1788520232,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (PLSE) announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","PLSE","NQmain","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664362183","title":"Pulse Biosciences Grants Inducement Stock Options for 2,200 Shares at USD 52.68 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664362183","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664362183?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:00","pubTimestamp":1788519614,"startTime":"0","endTime":"0","summary":"Pulse Biosciences grants inducement stock options for 2,200 shares at USD 52.68 eachPulse Biosciences set inducement equity awards for two newly hired employees on Sept. 2, 2026.Stock options cover 2,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbWZwkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238868","title":"Top Executive Makes Bold Insider Move at Pulse Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238868","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238868?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:09","pubTimestamp":1788401383,"startTime":"0","endTime":"0","summary":"New insider activity at Pulse Biosciences ( ($PLSE) ) has taken place on September 2, 2026. Pulse Biosciences has drawn insider confidence as COO L...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-at-pulse-biosciences-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-insider-move-at-pulse-biosciences-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842971","title":"Pulse Biosciences COO Liane Rae Teplitsky Acquires USD 100,000 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842971","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842971?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:46","pubTimestamp":1788392775,"startTime":"0","endTime":"0","summary":"Pulse Biosciences COO Liane Rae Teplitsky acquires USD 100,000 of common sharesPulse Biosciences COO Liane Rae Teplitsky bought 2,025 common shares in open-market purchases at USD 48.8 to USD 49.95.Di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL2RGHNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulse Biosciences COO Liane Rae Teplitsky Acquires USD 100,000 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019830","title":"Pulse Biosciences COO Liane Rae Teplitsky Reports Purchase of 2,070 Shares Worth $100,003.56","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019830","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019830?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:49","pubTimestamp":1787960964,"startTime":"0","endTime":"0","summary":"Pulse Biosciences COO Liane Rae Teplitsky reports purchase of 2,070 shares worth $100,003.56Pulse Biosciences COO Liane Rae Teplitsky bought 2,070 common shares in open-market transactions.Purchases w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL2lLmKd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulse Biosciences COO Liane Rae Teplitsky Reports Purchase of 2,070 Shares Worth $100,003.56","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016704","title":"Pulse Biosciences CFO Jon Skinner Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016704","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016704?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:15","pubTimestamp":1787958935,"startTime":"0","endTime":"0","summary":"Pulse Biosciences CFO Jon Skinner files initial beneficial ownership statementPulse Biosciences CFO Jon Skinner filed an initial Form 3 on Feb. 3, 2025.Disclaimer:This news brief was created by Public","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4fBkDx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464882","title":"Pulse Biosciences announces inducement grants under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464882?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:10","pubTimestamp":1787051442,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (PLSE) announced that the Compensation Committee of its Board of Directors has granted equity awards to five new employees as equ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","BK4082","PLSE","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461694","title":"Pulse Biosciences Grants Inducement Stock Options for 16,950 Shares at $44.92 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461694","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461694?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:00","pubTimestamp":1787050847,"startTime":"0","endTime":"0","summary":"Pulse Biosciences grants inducement stock options for 16,950 shares at $44.92 eachPulse Biosciences granted inducement stock options to five new employees covering 16,950 shares, issued Aug. 13, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8dJksD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660246165","title":"Pulse Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660246165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660246165?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:00","pubTimestamp":1787050803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA6BG5RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660869484","title":"Needham Initiates Pulse Biosciences at Buy With $58 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660869484","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660869484?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:57","pubTimestamp":1786964220,"startTime":"0","endTime":"0","summary":"Needham Initiates Pulse Biosciences at Buy With $58 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481741","title":"Pulse Biosciences Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481741","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481741?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:47","pubTimestamp":1786963620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PLSE/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660810563","title":"Pulse Biosciences Rides Strong Trial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2660810563","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660810563?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:16","pubTimestamp":1786925819,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc (($PLSE)) has held its Q2 earnings call. Read on for the main highlights of the call. Pulse Biosciences’ latest earnings call...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-rides-strong-trial-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-rides-strong-trial-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGLO","PMDE","VGFPF","BK4082","GXDW","JOYT","DECU","FEBU","PLSE","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658093381","title":"Pulse Biosciences price target raised to $43 from $32 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2658093381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658093381?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:20","pubTimestamp":1786360841,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on Pulse Biosciences (PLSE) to $43 from $32 and keeps a Buy rating on the shares. The firm said Pulse cont...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-price-target-raised-to-43-from-32-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-price-target-raised-to-43-from-32-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658338079","title":"Pulse Biosciences price target raised to $45 from $30 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2658338079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658338079?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:20","pubTimestamp":1786360836,"startTime":"0","endTime":"0","summary":"Mizuho analyst Anthony Petrone raised the firm’s price target on Pulse Biosciences (PLSE) to $45 from $30 and keeps an Outperform rating on the sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-price-target-raised-to-45-from-30-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pulse-biosciences-price-target-raised-to-45-from-30-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657254396","title":"Sector Update: Healthcare Stocks Rise Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2657254396","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657254396?lang=en_us&edition=fundamental","pubTime":"2026-08-08 03:49","pubTimestamp":1786132179,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF  up 0.6%.The iShares Biotechnology ETF  climbed 2%.In corporate news, Doximity  reported higher fiscal Q1 revenue late Thursday, beating consensus but adjusted earnings missed estimates. On the company's post-earnings conference call, per a FactSet transcript, Chief Executive Jeffrey Tangney said the revenue that Doximity's new AI search tool is generating is 10 times what it costs to run. Doximity shares surged 36%.Pulse Biosciences  shares jumped past 9% in Friday trading, a day after the company reported its Q2 results.Neurocrine Biosciences  shares gained 2.8% after the company said Friday it has started a phase 1 first-in-human trial of NBIP-1968, an experimental drug for obesity.ANI Pharmaceuticals  shares were down 5.9% even after it posted higher Q2 adjusted earnings and net revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0566484027.USD","BK4007","BK4585","BK4613","XBI","BK4539","LU2324357040.USD","BK4588","NBIX","BK4551","LU0128526141.USD","BK4167","BK4581","LU2065171402.SGD","LU0109394709.USD","LU0029874061.USD","LU0154245673.USD","LU0154245756.USD","BK4139","IBB","LABU","LU0889565916.HKD","DOCS","BK4137","LU2065170008.USD","LU0320765992.SGD","LU2065169927.USD","LU2065171311.SGD","PLSE","LU0823416689.USD","ANIP","BK4082","HCSG","LU1559883803.SGD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657762317","title":"Pulse Biosciences Shares Rise After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657762317","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657762317?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:55","pubTimestamp":1786128912,"startTime":"0","endTime":"0","summary":"Pulse Biosciences  shares were up 6.6% in Friday trading, a day after the company reported its Q2 results.The company posted a Q2 net loss of $0.36 per diluted share, widening from a loss of $0.28 a year earlier.Three analysts polled by FactSet expected a $0.36 loss.Revenue for the quarter ended June 30 was $434,000.Three analysts expected $500,000.Pulse Biosciences said cash and cash equivalents totaled $101.6 million as of June 30.Price: 40.76, Change: +2.52, Percent Change: +6.58","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661892","title":"Pulse Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661892","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661892?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:41","pubTimestamp":1786056073,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryPulse Biosciences IncPLSE.OQreported a quarterly adjusted loss of 36 cents per share for the quarter ended June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657699916","title":"Pulse Biosciences Enters Equity Distribution Agreement for up to $75 Million At-the-Market Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2657699916","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657699916?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:16","pubTimestamp":1786054605,"startTime":"0","endTime":"0","summary":"Pulse Biosciences enters equity distribution agreement for up to $75 million at-the-market offeringPulse Biosciences entered an equity distribution agreement with Mizuho to sell up to USD 75 million o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL1tdvGq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657566945","title":"Pulse Biosciences Launches $75 Million ATM Equity Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2657566945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657566945?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:13","pubTimestamp":1786054429,"startTime":"0","endTime":"0","summary":"The latest update is out from Pulse Biosciences ( ($PLSE) ). On August 6, 2026, Pulse Biosciences, Inc. entered into an equity distribution agreeme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-launches-75-million-atm-equity-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-launches-75-million-atm-equity-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","REZ","EQR","BK4585","PLSE","BK4082","VMRK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650423","title":"Pulse Biosciences Q2 Net Loss Widens, Cash Position Strengthens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650423","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650423?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:21","pubTimestamp":1786047690,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Q2 net loss widens, cash position strengthensOverviewBioelectric medicine company's Q2 2026 revenue grew sequentially during controlled commercial launchGAAP net loss for Q2 widened ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","LFSC","LU2065171402.SGD","BK4082","MYO","LU2065169927.USD","LIVN","PLSE","LU2065170008.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulsebiosciences.com","stockEarnings":[{"period":"1week","weight":0.1266},{"period":"1month","weight":0.4333},{"period":"3month","weight":1.1599},{"period":"6month","weight":2.016},{"period":"1year","weight":2.6498},{"period":"ytd","weight":2.9847}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.039406},{"month":2,"riseRate":0.4,"avgChangeRate":0.027622},{"month":3,"riseRate":0.4,"avgChangeRate":0.019181},{"month":4,"riseRate":0.5,"avgChangeRate":0.108995},{"month":5,"riseRate":0.4,"avgChangeRate":0.019334},{"month":6,"riseRate":0.545455,"avgChangeRate":0.015935},{"month":7,"riseRate":0.545455,"avgChangeRate":0.036341},{"month":8,"riseRate":0.636364,"avgChangeRate":0.041114},{"month":9,"riseRate":0.545455,"avgChangeRate":0.122113},{"month":10,"riseRate":0.3,"avgChangeRate":0.008129},{"month":11,"riseRate":0.5,"avgChangeRate":0.107856},{"month":12,"riseRate":0.6,"avgChangeRate":0.087874}],"exchange":"NASDAQ","name":"Pulse Biosciences","nameEN":"Pulse Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pulse Biosciences,PLSE,Pulse Biosciences股票,Pulse Biosciences股票老虎,Pulse Biosciences股票老虎国际,Pulse Biosciences行情,Pulse Biosciences股票行情,Pulse Biosciences股价,Pulse Biosciences股市,Pulse Biosciences股票价格,Pulse Biosciences股票交易,Pulse Biosciences股票购买,Pulse Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}